Treatment of Chronic Spontaneous Urticaria
Open Access
- 1 January 2012
- journal article
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 4 (6) , 326-331
Abstract
Kaplan AP. Allergy Asthma Immunol Res. 2012 Nov;4(6):326-331. http://dx.doi.org/10.4168/aair.2012.4.6.326Keywords
This publication has 55 references indexed in Scilit:
- A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine–refractory chronic idiopathic urticariaJournal of Allergy and Clinical Immunology, 2011
- Omalizumab is effective in nonautoimmune urticariaJournal of Allergy and Clinical Immunology, 2011
- Importance of Antigen Selection in the Detection of Autoantibodies against FcεRIα in Chronic Urticaria PatientsJournal of Allergy and Clinical Immunology, 2010
- Maintenance of Remission With Low-Dose Omalizumab in Long-Lasting, Refractory Chronic UrticariaAnnals of Allergy, Asthma & Immunology, 2010
- Guidelines for evaluation and management of urticaria in adults and childrenBritish Journal of Dermatology, 2007
- Autoantibodies to the high-affinity IgE receptor in children with chronic urticariaAnnals of Allergy, Asthma & Immunology, 2006
- Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticariaJournal of Allergy and Clinical Immunology, 2004
- A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticariaJournal of Allergy and Clinical Immunology, 2002
- Randomized double-blind study of cyclosporin in chronic ‘idiopathic’ urticariaBritish Journal of Dermatology, 2000
- A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria☆☆☆★Journal of Allergy and Clinical Immunology, 1999